<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02628249</url>
  </required_header>
  <id_info>
    <org_study_id>IAAO-EA</org_study_id>
    <nct_id>NCT02628249</nct_id>
  </id_info>
  <brief_title>Rate-limiting Amino Acids in Endurance-trained Athlete</brief_title>
  <acronym>EA</acronym>
  <official_title>Application of Indicator Amino Acid Oxidation Method to Investigate the Rate-limiting Amino Acids in Endurance Trained Athlete</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Protein requirements in individuals who participate in endurance-based exercise training have
      been suggested to be greater than the current recommended dietary allowance (RDA).

      The biological value of protein depends on the amino acid composition. As liebig's law of the
      minimum, the protein synthesis is limited due to the lack of single rate limiting amino acid.
      In this case, the first rate limiting amino acid determines protein intakes to maximize the
      protein synthesis. Adding a small amount of rate-limiting amino acid to the diet improves the
      biological value of its protein diet.

      The indicator amino acid oxidation (IAAO) method has clarified the individual amino acid
      requirement in children, normal healthy adult and clinical populations. however, the IAAO
      method has never been utilized for determining the first rate limiting amino acid.

      Therefore, the purpose of this study is to address of IAAO method to be applied for
      determining the rate-limiting amino acid in endurance athlete.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>13CO2 (carbon dioxide) excretion rate (μmol/kg/h)</measure>
    <time_frame>At 8 hours after the end of exercise</time_frame>
    <description>8 hours after exercise followed by ingesting 13C-labelled phenylalanine and one of 5 different amount of amino acids intake, 13CO2 excretion rate is determined by multiplying the enrichment of 13CO2 in breath measured by Mass spectrometry and CO2 production rate measured by metabolic cart.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>[13C]phenylalanine oxidation rate (μmol/kg/h)</measure>
    <time_frame>at 8 hours after the end of exercise</time_frame>
    <description>8 hours after exercise followed by ingesting 13C-labelled phenylalanine and one of 5 different amount of amino acids intake, 13CO2 excretion rate is determined dividing 13CO2 excretion rate by urinary enrichment of 13C-phenylalanine in breath measured by Mass spectrometry, and CO2 production rate measured by metabolic cart.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Increased Metabolic Requirement</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Base protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.8 g/kg/d of protein provided as crystalline amino acid made after egg protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sufficient protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.75 g/kg/d protein provided as crystalline amino acid made after egg protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Base + BCAA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Base protein intake + Branched chain amino acids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Base + EAA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Base protein intake + essential amino acids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Base + NEAA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Base protein intake + non essential amino acids</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Base protein</intervention_name>
    <description>0.8 g/kg/d of protein provided as crystalline amino acid modeled after egg protein</description>
    <arm_group_label>Base protein</arm_group_label>
    <arm_group_label>Base + BCAA</arm_group_label>
    <arm_group_label>Base + EAA</arm_group_label>
    <arm_group_label>Base + NEAA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sufficient protein</intervention_name>
    <description>1.75 g/kg/d protein provided as crystalline amino acid modeled after egg protein.</description>
    <arm_group_label>Sufficient protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Branched chain amino acids</intervention_name>
    <description>Branched chain amino acids modeled after egg protein.</description>
    <arm_group_label>Base + BCAA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Essential amino acids</intervention_name>
    <description>Essential amino acids modeled after egg protein.</description>
    <arm_group_label>Base + EAA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Non essential amino acids</intervention_name>
    <description>Non essential amino acids modeled after egg protein.</description>
    <arm_group_label>Base + NEAA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Gender: Male

        Age limit: Minimum age 18 years - Maximum age 35 years

        Accepts Healthy Volunteers : yes

        Inclusion Criteria:

          -  Endurance-trained participants who regularly more than 40 km/week

          -  Ability to perform the exercise stimulus (20 km run) on metabolic trial.

        Exclusion Criteria:

          -  Inability to meet health and physical activity guidelines according to the physical
             activity readiness questionnaire (PAR-Q+)

          -  Inability to adhere to any of the protocol guidelines (i.e. alcohol, caffeine
             consumption)

          -  Regular tobacco use

          -  Illicit drug use
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2015</study_first_submitted>
  <study_first_submitted_qc>December 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Daniel Moore</investigator_full_name>
    <investigator_title>Assistant professaor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

